Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Claudia Pirisi"'
Autor:
Carlos E. Araujo, Luis Balbiani, Claudio Savulsky, Juan C. Cervellino, Carlos Sparrow, Mario F. Bruno, Norberto Brocato, Guillermo Temperley, Claudia Pirisi
Publikováno v:
Oncology. 52:24-31
203 patients with inoperable non-small cell lung cancer (NSCLC) were randomized to receive ifosfamide (IFO) 2.5 g/m2 days 1-2 + epirubicin (EPI) 70 mg/m2 day 1 with cisplatin (DD
Publikováno v:
Journal of Surgical Oncology. 46:198-202
Twenty-one evaluable patients with FIGO stages II-IV epithelial ovarian cancer, median age 57 (range 47-75 years), were treated with ifosfamide (IF), 3 g/m2 diluted in 500 ml saline solution, 8 hour intravenous (i.v.) infusion on days 1-5; mesna 20%
Publikováno v:
Oncology. 48:89-92
High-dose ifosfamide/mesna was administrated to 28 mostly pretreated patients with locally advanced and metastatic head and neck cancer who failed conventional surgery/radiation treatment. Primary sit
Autor:
Rodolfo Rossi, Carlos E. Araujo, Miguel Brosto, Claudia Pirisi, Osvaldo Sánchez, Juan C. Cervellino
Publikováno v:
Cancer Chemotherapy and Pharmacology. 26:S1-S3
This study was carried out to assess the efficacy of high-dose ifosfamide/mesna (HDIFM) in the treatment of advanced or recurrent cancer of the cervix. In all, 18/21 evaluable patients with advanced or inoperable cervical cancer were included. The me
Publikováno v:
Journal of surgical oncology. 43(4)
Fifty-one patients with stage D prostate cancer, who had failed primary hormone treatment, were treated with diethylstilbestrol diphosphate (DES-DP) 1.5 g 24 hr intravenous infusion from day 1 to day 7 (group A). In group B, patients were treated wit